Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00217386 · COMPLETED

Trial details

NCT number: NCT00217386
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases

Start date: 2004-03-01
Primary completion: 2007-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.